
Journal of Organic Chemistry p. 8006 - 8018 (2019)
Update date:2022-07-30
Topics:
Molinaro, Carmela
Phillips, Eric M.
Xiang, Bangping
Milczek, Erika
Shevlin, Michael
Balsells, Jaume
Ceglia, Scott
Chen, Jiahui
Chen, Lu
Chen, Qinghao
Fei, Zhongbo
Hoerrner, Scott
Qi, Ji
De Lera Ruiz, Manuel
Tan, Lushi
Wan, Baoqiang
Yin, Jingjun
A practical and efficient enantioselective synthesis of the calcitonin gene-related peptide receptor antagonist 1 has been developed. The key structural component of the active pharmaceutical ingredient is a syn-1,2-amino-fluoropiperidine 4. Two approaches were developed to synthesize this important pharmacophore. Initially, Ru-catalyzed asymmetric hydrogenation of fluoride-substituted enamide 8 enabled the synthesis of sufficient quantities of compound 1 to support early preclinical studies. Subsequently, a novel, cost-effective route to this intermediate was developed utilizing a dynamic kinetic asymmetric transamination of ketone 9. This synthesis also features a robust Ullmann coupling to install a bis-aryl ether using a soluble Cu(I) catalyst. Finally, an enzymatic desymmetrization of meso-diester 7 was exploited for the construction of the γ-lactam moiety in 1.
View Morewebsite:http://www.synchemie.com/
Contact:+86-574-87642758
Address:Room 901, Yinyi Bund Building, 132 Renmin Road
VanderArk International Limited
Contact:86-10-82437576
Address:Qing He
He Bei Shun Er Chemical Co., LTD.
Contact:86-0311-86996932/86860168
Address:No 18,North street
Changsha Nutritopper Bio Technology Co.,Ltd.
Contact:+86-731-87803543
Address:East 1st Street, Baima Road, Ningxiang County
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Doi:10.1016/S0040-4039(03)00614-2
(2003)Doi:10.1002/anie.201301591
(2013)Doi:10.1023/A:1012380212140
(2001)Doi:10.1039/jr9480002138
(1948)Doi:10.1002/cssc.201900928
(2019)Doi:10.1016/S0040-4039(00)78844-7
(1980)